NCT03228290 Functional Assessment in Liver Transplantation
| NCT ID | NCT03228290 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | End Stage Liver Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2011-10-12 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2011-10-12 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This will be a prospective cohort study of patients with liver disease. Subjects will undergo geriatric assessments of frailty, functional status, and disability using functional status measures at baseline and at every clinic visit in the pre-transplant setting. Subjects will also answer questions regarding quality of life, personality, and/or cognitive function. Subjects will again undergo assessments at every clinic visit through 12 months after transplant. Then, they will be followed annually.
Eligibility Criteria
Inclusion Criteria: * Adult (≥18 years old) * Are seen for the treatment of liver disease
Contact & Investigator
Jennifer C Lai, MD, MBA
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT03228290 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying End Stage Liver Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03228290 currently recruiting?
Yes, NCT03228290 is actively recruiting participants. Contact the research team at jennifer.lai@ucsf.edu for enrollment information.
Where is the NCT03228290 trial being conducted?
This trial is being conducted at Little Rock, United States, Loma Linda, United States, San Francisco, United States, Chicago, United States and 8 additional locations.
Who is sponsoring the NCT03228290 clinical trial?
NCT03228290 is sponsored by University of California, San Francisco. The principal investigator is Jennifer C Lai, MD, MBA at University of California, San Francisco. The trial plans to enroll 5,000 participants.